A Study of The Effects of Co-Administering Ciprofloxacin and BioThrax on the Pharmacokinetics of Ciprofloxacin in Healthy Adults
Phase of Trial: Phase II
Latest Information Update: 15 Dec 2014
At a glance
- Drugs Anthrax vaccine (Primary) ; Ciprofloxacin (Primary)
- Indications Anthrax
- Focus Pharmacokinetics; Registrational
- Sponsors Emergent BioSolutions
- 16 Apr 2014 Emergent BioSolutions has submitted the final clinical study report to the Biomedical Advanced Research and Development Authority (BARDA) and the US FDA.
- 16 Apr 2014 Primary endpoint 'Peak-drug-concentration' has been met.
- 16 Apr 2014 Primary endpoint 'Area-under-the-drug-concentration-time-curve' has been met.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History